Insider trades
Matthew Vincent Dolan, EVP of Dexcom DXCM, has filed 0 purchases and 11 sales on the open market. The latest trade was on 25/01/29.
Matthew Vincent Dolan
EVP, Strategy & Corporate Dev
- Company
- Dexcom DXCM
- First filing
- 23/03/17
- Trades
- 18 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- No record
- Last trade
- 25/01/29
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
DexcomDXCM | Open-market sale | 25/01/29 | 25/01/30 | 1,183 sh | $86.91 | $102,814.53 | −2.7% |
DexcomDXCM | Open-market sale10b5-1 plan | 24/05/15 | 24/05/16 | 2,423 sh | $126.58 | $306,703.34 | −5.7% |
DexcomDXCM | Open-market sale10b5-1 plan | 24/04/15 | 24/04/16 | 1,990 sh | $137.81 | $274,241.9 | −4.5% |
DXCM | Open-market sale10b5-1 plan | 24/03/15 | 24/03/19 | 4,203 sh3 trades | $130.20avg. | $547,249.43 | −8.7% |
DexcomDXCM | Open-market sale | 24/03/12 | 24/03/14 | 6,710 sh | $134.41 | $901,891.1 | −12.1% |
DexcomDXCM | Open-market sale | 23/09/01 | 23/09/01 | 56 sh | $102.32 | $5,729.92 | −0.2% |
DexcomDXCM | Open-market sale | 23/03/16 | 23/03/17 | 2,303 sh | $115.00 | $264,845 | −6.4% |
DexcomDXCM | Open-market sale | 23/03/13 | 23/03/14 | 6,229 sh | $106.27 | $661,955.83 | −14.8% |
DexcomDXCM | Open-market sale | 23/03/06 | 23/03/06 | 226 sh | $114.40 | $25,854.4 | −0.8% |